Seeking Alpha

Keryx Biopharmaceuticals (KERX) and AEterna Zentaris (AEZS) move lower in premarket trading...

Keryx Biopharmaceuticals (KERX) and AEterna Zentaris (AEZS) move lower in premarket trading after the credibility of Jeremy Richards is openly questioned by Adam Feuerstein. Richards claimed that FDA approval on colon cancer drug perifosine was "practically a done deal" in a SA piece. KERX -7.7%, AEZS -12.2%.
Comments (1)
  • KJP712
    , contributor
    Comments (437) | Send Message
     
    Looks like someone big had to get out of their short position.Keep the faith and buy more at these prices.Actually the article yesterday was right on target.
    6 Mar 2012, 10:58 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|